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1.  Article  23  of  Council  Directive  86/609/EEC( 1 )  on  the 
approximation 
provisions  of 
of  laws, 
the Member 
regulations 
States  regarding 
and  administrative 
the protection  of 
animals  used  for experimental  and  other  scientific  purposes 
reads  : 
"ArticlP.  23 
1.  The  Commission  and  Member  States  should  encourage 
research  into  the  development  and  validation  of 
alternative  techniques  which  could provide  the  same  level 
of  information as  that  obtained  in  experiments  using 
animals  but which  involve  fewer  animals  or which entail 
less  painful procedures,  and  shall take  ouch  other steps 
as  they consider  appropriate to  encourage  research  in 
this  field.  The  Commission  and  Member  States  shall 
monitor  trends  in experimental methods. 
2.  The  Commission  shall report before the end  of  1987  on 
the  possibility of  modifying tests  and guidelines  laid 
down  in  existing  Community  legislation  taking  into 
account 'the objectives referred to in paragraph 1." 
2.  As  a  background  it is useful  to clarify what  is meant  by  a 
toxicity test and  to describe  some  of  test procedures  which  are 
commonly  used; 
Table  1. 
a  summary  of  this  information  is  given  in 
3.  While  it is  difficult to  obtain  precise  information  on 
animal  experimentation  throughout  the  Community,  a  conservative 
estimate of  the total number  of  animals  used  each  year would  be 
around  10  million of  which  about  20  % are  used  for  the  purr:>ses 
of  satisfying  regulatory requirements;  of  the  remaining  80  % 
the  majority  are  used  either  for  academic  research  or 
(1)  O.J.  No.  L  358,  18.12.86,  p.  1 - 3  -
industrial  research  and  development.  It  follows  that 
modifications  to  regulatory testing requirements  can  only have 
an  impact  for  the  20  % of  animals  used  for  such  purposes. 
4.  Several  pieces  of  Community  legislation  explicitly  or 
implicitly require  animal  testing to be  carried out  <see  Table 
2).  A detailed description of  the testing requirements  allied 
to each  piece of  legislation can  be  found  in  EUR  Report  11353 
"EEC  Directives  and  Animal  Testing". 
5.  In  the majority  of  cases,  references  to  animal  testing in 
Community  legislation take  the  form  of  guidelines,  or notes  for 
guidance,  concerning  necessary toxicological data which  should 
accompany  an  application for the placing  on  the market,  or the 
use,  of  certain products  or ingredients.  In  some  instances 
such guidelines,  or notes  for guidance,  form  part of  the text 
of  the  legislation itself,  as  is the  case  for pharmaceuticals• 
(see  Council  Recommendations  83/571/EEC  and  87/176/EEC>, 
whereas  for  other product  areas  they  have  been  elaborated by 
one  of  the  Communities'  Scientific Advisory Committees  (see  for 
example  Report  of  the Scientific Advisory  Co~nittee for  Food  -
"Guidelines  for  the Safety  Assessment  of  Food  Additives" 
opinion of  22nd  February  1980  contained  in  EUR  Report  6892  or 
Report  of  the Scientific  Committee  on  Cosmetology  - "Notes  of 
guidance  for  the toxicity  testing of  cosmetic  ingredients"  -
opinion of  28  June  1982  contained  in  "EEC  Environment  and 
Quality of  Life"  1983). 
Where  use  is made  of  guidelines  or notes  for  guidance  the 
precise  ~etails  of  the  testing methods  to  be  used  are  not 
spelled out  and  readers  are usually  referred to  0~pro~~~.n~t! 
intnrn:1t~onally accepted  testing methods.  Frequently  reforre~ 
to  sou~ces  for detailed testing methods  are  the guidelines  for 
the  t0~;ti  ng  of  chemicals  published  by  the  OrlJanization  of 
Economic  Co-operation  and  Development  <Annex  1  to  Decision of .  4  -
OECD  Council  C(81)30  1901).  The  European  Pharmacopoeia 
<elaborated  under  the  auspices  of  the  Council  of  E11rops)  and 
the  Communi·tics'  ow·n  cherrd.cals  control  lc-:Jg.i.f;lat..i.on  <Cc..n1ncil 
Directive  67/548/EEC  (see  para  G  below) l.  The  usa  of 
guideli~~~,~"':"P~~;.~~,ij,~tes  for  guidance  oft:  on  ullown  ~mf  f .i.ciont. 
flexibiri~,~\Vv~V;;i:j;i;.;O;Jthat  al.tel:'native  methods  ( sr=e  parn.  9 >  can  be 
used  lls  and  ~)l~n they  become  available. 
G.  J)i:t:ect.ive  67/548/EEC  as  amenclGcl  for  tho  ~.i.xtl1  time  by 
Directive  79/831/EEC  concerns  the  classification,  packaging  and 
labelling  c:.,f  dcmgerous  substances.  'rho  DiJ.'t~ct.:i.v~  J7CJCJILi.J:as  thot 
bo:t·oro  a  n~w .substance  cr.t.n  bG  plr.tc<.~d  on  t:l1o  m,'.lrl::c)t  c.'  tc,:clm:tc,·;l 
do  f. sier  mu~t  be  submitted  containing  1  c:Hnon~J  other:  :i. nfon1W 'Lion, 
toxicological data,  inclucli.n9  l~D!)O  valum1 1  and  tl1n  )':osult~>  cYf 
0ye  ~nd  skin  .i.r.;d.tat.i.on  ter.;ts.  'J.'he  l1\('d:hodl;  \\'ld  .. ch  htJV(-~  to  be 
follO\vod  i.n  c;ompleting  thGsG  test.:::;  a.1.·c  dosc:c:.i.bc:d  :Ln  cl()1:H.i.J  .{n 
Ann~x V  of  the  Direct:i.Vl;l,  tho  f.ir.s'l:.  part of  whir.h  \\'r:s  pnhl:i.!;hc:ld 
as  a  Commission  Dj.n.Jctive  .i.n  19f34  (04/449/EECl  Ot:l':E":l7  p.i.nc:8~>  df 
Co1~unity legislation,  existing  and  proposod,  rof0r  to  the 
tc~st:i.ng  rn~::1thods  raquirad  undc:c  D.i.l~~ct:i.v<-:  G'7/~itlfl/J.:i•!C,  u;g. 
additives  in  c:mimnl  nutrition, .'Ccmncil  Di:r.GcU.ve  (l'//J.!j3/!:F;C  and 
the  Commission  pl.:opof.Hll  for  n  CO\Jncj J  DJ roc  l:i  vc~  cc;ncc~rn.tng 
..J
1
,  """'"'0  "'  f  t'  (C0M(8 1;)36"  fl.'I"I"l) ( 2).  IJuTl~.;)  ...  u.,  >repara. :.tons  .- ·1  ._. 
Directive  67/548/EEC 
legislation wl1ich  has 
is  n 
harmoni~Gd  chemical~ 
o£  c:~,:,;muni ty 
contJ:ol  in  t:lH:: 
Conummi t:y.  However,  it  has  froquon'l:ly  hc~c;m  cd.  U.  •~r.:d  as  a  piece 
o~  legislation entailing unnecessary  testing. 
ln  tho  flJGC 
of  such  criticism it  hns  to  be  pointed  out:  ·tJwL  bcd'onl  its 
introduction each  of  the  Communities'  tlc:mbflJ:  Str~tN;  could 
require different  information to  be  suppl.i.c~<l  bnfon~  substanc~1s 
ware  pluced  on  the  market  cHld  t:hat  thi.::..>  often  Jr.,d  to  ·a 
'duplication of  animal  testi.ng.  Now,  with  th8  mutuul.  accoptnnce 
'  of:  data.,  tGsts  only .  need  to  be  caJ:~·ied  Oti t:  o:1co  acco;:cl;Lng  to 
C  2 >  0. J.  No.  C  211,  2 2. 0 8. 8 5,  p.  3 - 5  -
'· 
the prescribed  method  and  the  r<?.nultB  Are  accepted  througho'\.11.:. 
the  Community.  It  is t:herefo:re  tmdoubtc:ldly  the  c~:.se  th:i1t 
Directive  67/540/EEC  hQS  brought  nbout  a  considerable  ~eduction 
on  the  total number  of  animals  used  for  chemicals  testing. 
Secondly,l...,~!l~...._.f!_umber  of  T.mi.mals 
requirC.'  •  ._._,_,,.._, ""'·.: .  .....,..,;tm1ica 1  l:'Ggu la  tion 
less  than  5~ ·~~·  the total  numbcl~ of 
used  fm.:  sat:Lsfying  the 
testing  probably  ropreGcnts 
anil\\aln  usod  nnnualJ.y.  'l'he 
~ 
Commission  ie  1  liowever  1  sens  H:ivo  t:o  its  :r(Hiponr.ib.i.l.i.U.r.:ls  to 
rc:mc:lw  tho  tooting  requircmentH  of  DiJ:ective  Ci'7/540/EBC  nnrl  an 
updating  procedure  has  olreo.dy  bGen  :i.ni  t.i.ri t:od  '<  sGc  pnrn. 16) . 
7.  The 
out.  iB 
reason  why 
to ensure 
toxicity tooting 
ndequate  protection 
io  roquirclcl  to  l>o  carJ:J.~~cl 
1oJ~  11Hm  <'.tnd./cn7  othc:~J~ 
spocif.i.c  t:arget  spcciun e.g.  i1.1.1:m  uninw1r.,  llncl  .ilJ  r;on1o  c:c.l~H'~H, 
n~ldiU.onaJ.ly,  the  onvironmcmt.  The  ~:at.i.onale  hn1;  lloc:m.thnt  one 
cnrriets  out  tests  on  cex-t.uin  an:lmnJ.  E-~puc::.Lm.i  ~:.:o  t.llu t.  from  the 
l~esult~  one  cnn  m:trnpolate  to  Uw  11kG.l.y  r1ffoct  c:m  man  OJ:  ,. 
other target  spocie~~  and. thnrehy  pl:ev·ont:  o:t;  cont~~n1  ·the  plac::i.l~g 
on  the  mcu:ket  of  pot.entially drmguJXltlH  p.rodnct.s;  impli.c.i.t  {n 
such  nn  approach is tho  ll.C,CGpt:nnce  t.hat  tl·la  ur1.i.mnl  :;p<"Jc:l en;  us<::1d 
in testing are appropriate mddels  for the  Gpacico  ono  is  tryi11g 
to protEJct. 
8.  In  recent years  the 'testing  schemes  usud  for  rogulato~v 
purposes  hnvc  been  t.hc  subject:  of  cr.iticism  from  the  point  of  view 
6f  their-ricientific validity, and  there  has  been  mounting  pressure  to 
introduce  ~cthods using  fewer  or  np  vertebrate animals. 
Whil0  the  Commi.£H.;ion  is  committed  to  tho  objcctivo of  acU.voly 
seeking  such  al  tarnati  vo  method5  it  cons.i.d(~l7S  tlw  t  :L t~; · pr.i.nllll.'Y 
responsibility lies  in  prot(~ct.i.n9 ·man  and  the  onvi.T:onmenl:  frorn 
tho rinks  arising  from  the  placing  on  the market  of  potentially 
dangeroun  products,  'l'herefo:r:-e,  tho  CommiusJ.on  wiJ.J.  only 
consider the  acceptance  of  an  alternative  rnothod  when  it hrJ.s 
fi: 
.1!  •.  .-5 - 6  -
been demonstrated  that it  affords the  same  level of  security 
for the  protection of  man  and  the  environment  as  the existing 
procedure(s)  it is designed to replace  (see para 12). 
9.  Before  considering the  opportunities for  the  amendment  of 
current test  guidelines it  is useful to discuss what is meant 
by an  alternative or  modified  method.  Russell  and  Burch 
*  (1959>  proposed  that alternatives  could be  considered under 
three headings  reduction,  refinement  or replacement  (the  ·so 
called 3Rs). 
- reduction alternatives,  which  reduce  the number  of  animals 
required; 
~t!t\ 
-refinement altern0tjve§,  which diminish  the"amount  ofpain 
and distress  suffered by animals  used  in testing procedures; 
- replacement alternative§,  which  completely  replace  animal 
experiments. 
The principal  types  of  technique  which  lead  to 
refinement or  replacement  of  animals  tests  are 
Table  3. 
reduction, 
listed  in 
10.  At  the present  time the majority of  proposed alternatives 
fall under the headings  of  refinement  or reduction  and  although 
methods  involving  replacement  by non 
orders  of  organisms  are  available 
developed to  the  stage  where  they 
sentient material or  lower 
few,  if 
could 
any,  have 
be  prorJosed 
been 
for 
acceptance within  a  regulatory  testing system  <Table  4).  In 
addition,  the  development  of  new methods  has  to  a  large extent 
been concentrated on  the identification of  alternatives  for the 
acute .toxicity  testing procedures  e.g.  the  acute  LDSO  and 
Draize tests  (see para  2>. 
<*>  Rusell,  vn1S  and  Burch  RL  (1959)  Principles  of  Human 
Experimental  Techniques  <Methuen  London) - 7  -
The  opportunities  available to  the  Commission  for  immediate 
action  are  consequently  limited  to  those  few  alternative 
methods  which  have  gained widespread  acceptance. 
11.  There  is considerable  research activity within the Member 
States directed  towards  the  development  of  alternative  test 
methods.  In addition,  the  4th  European  Community  Environmental 
Protection Research  ann  Development  Programme  (1986-1990)  and 
The  European  Community  Biotechnology  Action  Programme  <1986-
1989)  both  include  research  initiatives  which  should  lead 
directly or  indirectly towards  the  same  goal.  Furthermore,  a 
number  of  studies  have  been  financed  within  the  framework  of 
the  European  Communities  Toxicology  Action  Programme  with the 
objectives of  reducing  both  animal  usage  and  animal  suffering 
and  of  promoting  new  approaches  to  toxicity  testing, 
particularly jn vitro methods. 






which  govern  the 
test  methods  and  any 
proposed test method  must  undergo  rigorous  evaluation before it 
can  be  accepted at  a  regulatory  level.  While  the scientific 
merit  can  often be  assessed,  to  a  large  degree,  during  the 
early stages  of  development  (as part of  a  research  programme) 
there  comes  a  point  when  a  method  has  to be  evaluated against 
other  criteria  e.g.  practicality,  cost  effectiveness, 
repeatability,  comparison  with  methods  it  is  designed  to 
replace  and  comparison with  other alternative  methnrls.  This 
wider  evaluation  often involves  the  organisation  ;;f  "round 
robin"  or  "ring-test"  exercises  where  a  large  nurr.ber  of 
laboratories try out  the  proposed test procedure  using  the  same 
set of  reference  chemicals.  These  ring test exercises  often 
highlight practicial problems;  for what  may  be  common  place  in 
one  laboratory  may  present unexpected difficulties in another. 
It is  essential that  this  wider  evaluation  of  alternative - 8  -
methods  be  undertaken at  an  international  level  :  if a  method 
is only  accepted within  one  Member  State this  will  have  a 
negligible  impact.  The  Commission is  ideally placed  to co-
ordinate the  evaluation of  alternative methods  at a  Community 
level. 
13.  As  alternative methods  are developed it is important that 
potential users  <researchers,  industry,  regulators)  are aware 
of their  availability and  current  status  (early  stages  of 
development,  being ring-tested,  accepted  for regulatory testing 
etc.).  It is therefore  important,  both  from  the point of  view 
of  avoiding  duplication of  research effort as  well  as  from  the 
animal  welfare  perspective,  that  there  is  an  efficient 
procedure  for  information exchange.  Within  the  Community,  the 
Commission  is  ideally  placed  to  ensure  the  necessary  co-
ordination of  this  information  exchange. 
14.  It  is evident  that one  of  the major obstacles  towards  the 
acceptance  of  methods  to  replace the  classical LD50  testing 
procedure is  the  fact  that  many  nations  and  international 
bodies  use  the results  of  such tests as  a  means  of  classifying 
chemicals  <Table  5).  Therefore,  if  the  Community  were  to 
unilaterally adopt  non-LD50  testing  procedures  accompanied  by 
parallel changes  in its  classification scheme  this would,  in 
the absence  of  simular  modifications  by third countries,  only 
result in  Community manufacturers  having  to  carry  out  the 
normal  LD50  testing in  order to  export.  It  is  therefore 
essential that  any action  on  this question is  under~aken at an 
international level  and  in  a  harmonized manner. - 9  -
The  Commroission's  Proposals 
15.  From  the  foregoing it should  be  apparent that the  immediate 
opportunities  for  modifying tests  and  guidelines  in existing 
Community  legislation  are  limited.  The  Commission's  proposals 
are  therefore  predominantly  concerned  with  an  ongoing 
committment  to  the development  of alternative methods  and  the 
creation of  a  framework  wherein alternative  methods  can  be 
introduced in the legislation as  they become  available. 
16.  The  Council  of  the Organization for  Economic  Co-operation 
and  Development  adopted  on  24  February  1987,  updated versions 
of their  testing guidelines  401,  Acute  Oral Toxicity;  402, 
Acute  Dermal  Toxicity;  and  405,  Acute  Eye  Irritation.  The 
modifications  introduced  in these updated versions  include  the 
reduction of  the  numbers  of  animals  used  and  the reduction in 
the degree  of  suffering  experienced  by  the test animals.  The 
Commission  undertakes  to  introduce the necessary modifications 
to existing  Community  legislation.  In practice this will  mean 
the publication of  a  Commission  Directive adapting to technical 
progress  annex  V  of  Directive  67/548/EEC  (see para.  6); 
17.  The  Commission  will  continue to  be  involved with,  and  to 
support,  the  OECD's  updating  programme  with  respect  to  the 
guidelines  for testing of  chemicals. 




testing  (testing  for  fev~~-inducing 
is  required  in  registering  some 
Pyrogenicity  testing  normally  req~~res 
with the potential pyrogen  and  observing  any 
reactions  to  the  substance.  Extensive  work  has  been  done  to 
establish and  validate an  alternative test  for  pyrogenicity - 10  -
using  the  asiatic horseshoe  crab  (LimuJus  polyphemt~).  This 
test,  called  the  limulus  amoebocytelysate  (LAL)  test,  uses  an 
extract  from  the  blood cells of  the  crab which  can  be  used  for 
in-yjtro testing. 
into  the  European 
acceptable  under 
legislation. 
As  soon  as  this test method  is introduced 
Pharmacopoeia  it  will  automatically  be 
the  relevant  Community  pharmaceuticas 
19.  The  Commission  has  already initiated an  updating  programme 
for  Annex  V  of  Council  Directive  67/548/EEC  relating  to the 
classification,  packaging  and  labelling of  dangerous  substances 
(see para.6).  In  addition to  the proposals  indicated under 
para  16  (above)  the  Commission,  in consultation with the Member 
States,  will also evaluate the possibility of  introducing other 
alternatives  to  the current  LDSO  testing procedures  as well  as 
replacements  for  the current eye  and  skin irritation tests.  As 
and  when  such alternative  methods  are  accepted  they  will be 
introduced  into  Annex  V  of  the  Directive  by the publication of 
a  Commission  Directive  adapting  the  annex  to  technical 
progress. 
20.  The  Commission  proposes  to hold  an  international  symposium 
in  early  1989  to  explore  the  possibility  of  a  phased 
replacement  of  classical toxicity  testing methods  carried out 
for  the  purposes  of  classifying dangerous  chemicals. 
21.  The  Commission will  continue to  fund  research acti  vi  tie~>  in 
the  field  of  alternative test methods  (see para  11).  However, 
the  Commission  is aware  of  the considerable research  activj~ies 
taking place  within  the  Member  States,  both  publicly  and 
privately funded,  and  proposes  that the  Commisison  should  be - ll -
.l.nvoJ.ved  :i.n  the .CU=Q.ciLncthm  of  :i.nfo.1:mati.on  c>:chan9c-:  on  t.h0s8 
rcscorch  activitJ.os. 
22.  As  part of  thif3  co-ordinot.i.on  effo):t  tho  Comrn:L.'_;sion  would 
propose  to  fund  tho  development  of  n  European  Uatn  Rase  on 
Jl.lternat.ivo  'l'oxicity  rresting  Methods  such  tJ·li.lt.  );c;~warchor.s, 
industxy  and  govm:nments  could  be  immod.i.i.\toly  c::vrnn.!  of  t.ho 
developments 
act.i.vi'ty  to 
taking  plnce 
be  undertaken 
throughout~  t.11o  Comrnnr: i t:y; 
in  consultation 
such 
ot.he:r; 
i.nt:eJ=nationnl  bodies  e.g.  H.H.O ..  and  O.C.D.E.  In  Lhi_r,  context 
the  Comm.i.s~ion hns  already  estal".lliE;hod  nn  .i.nvcn·t01:y  of  iJL_Y5J.~l:Q 
testi~g fucilitj.es  within  the  Community. 
23.  'J'he  Comniis:sion  J:ecognizos  thtlt  n  c:ci.1:fcnl  r.t.a~l'';j  .i.n  tho 
dGv(d  opme:m t  of  nn  a 1 tern  a ti  vc  rnethod  is  Lhc:  t:r:tm  ~; i. t; :Lon  f rClll't 
t.hat  of:  c.l  pc>tent.i.aJ.J.y  useful  pl70CC~chu:r:-:  ·t:o  1'.hilt.  t:)f  il  rnc:l.l!od 
~'\ccoptec.l.  11s  pc:r.t  of  :r(:~gulatox·y  tc-:f:;t:ing  ::;~y::;;tom  ( r;c\:!  J:!i~l7D. .  .1./.). 
The:  Conm1inH.ion  therefore  proposo;.;  to  p:rov:i.clc.:~  <l  h:ilJ:·.c.~wor.k  l:c.ll': 
the.  cvt~luat1on of  altcrnatl\12  tc~1t  p):OcGdu:n~:7:. 
24.  'l'h('l  Conunission  will. mtlke  proposals  for  Comrnun:ity  c\(:tion  .i.n 
i11te:r:·11etion.l  fc)ra,  fJllrticulal~ly  .in  t..11e  CC)\lncil  c)f  J::u:~Oi)C  'll1d 
(J.C.D.E.,  ~vhore  C]ucstions  c,f  anirnul  c-~>\l_)C.::~~rjcr~":!';·~:<".!1..~.(.;l:  (::!d 
Cl">ll1J"On  action  by  t:hc  HembGr  f)tc:!tcs 1  \•;bon  1:1ppl.·opJ:i.r:  .-.  .-}  1  .i.n  ;·:r~;iJ!> 
cove2r:cd  by  Meil,11G1~  StntG  competencos. 
In  particular it  is  hoped  that,  dependent  upon  the  outcome  of  the  symposium 
rliJrrod  to  in  par~graph 20,  the  Commission  would  be  in  a  position to  formulate 
fl  ~lrOiJOsd  concern~n~ LDSO  testing during  the  course  of  1989. 
.JA: ···..1.. 
TABLE  1 
TOXICITY TESTING 
The  objoctivo  of  toxicity  tenting  io  to  mcnnurc  tho  toxic! ty  of  nny  nubotnncc  in 
ardor  to  detormlne  what  dooos  oro  uafo;  to  auoeos  the  typoo  of  Injury  which 
occur  If  onfo  lovoln  aro  oxceodod  nnd  thuu  to  onablo  calculotiono  of  risk  vorouo 
bonofit  end  method$  of  safe  handling  to  bo  drawn  up. 
TYfl?!3  of Toxicity 
Acute  toxicity  compriuoo  tho  offectn  found  within  a  few  doyo  of  u  singlo  dmm 
and  includoo  lethal  offocto.  An  LDso  value  Is  the  done  at  which  half  the  test 
animalo  con  (within  utatiotlcnl  limitn  of  confidence)  be  expected  to  dio. 
Expo!lurc  to  subotnnces  may  rooult  from  oovoral  routes  of  expooure  (og,  oral  ond 
lnholotlon). 
Su!>-~cuto  and  chronic  tmucity.  Repeated  smoll  doseo  ouch  on  oro  found  during 
medication  or  during  lnduotrlal  expoouro  may  couoo  Injury  to  quito  difforont 
ports  of  tho  body  frorn  thane  affected  by  acuto  exposure.  Animal  teotn  attempt 
to  reproduce  thin  oituotion,  tho  animals  oro  oxpooed  for  7,  30,  90  day  perlodn  or 
for  2  years  to  11 fctime  otudioa  in  tho  rnt.  The  onimnls  ore  obocrvod  for 
chongcs  in  behoviour,  chongoo  in  the  gross  and  micraocapic  otructuro,  nnd 
changeo  in  biochemiotry  of  blood  and  tissuc!l, 
Corcinogcnic  offcctn.  A  corcinogcn  In  o  nubotonco  which  cnu3es  cancer.  Short-
term  carcinogenicity  tosts  depend  on  the  oboorvation  thvt  n  mnjor  group  of 
cnrcinogono  cause · olterotiono  to  the  chornlcnl  ntructuro  of  tho  genetic  materi~l 
DNA.  Theoo  gonotoxic  mntorialo  con  bo  dotectod  by  their  cffcctn  in  cnw1ing 
mutation  in  bacterin  or  colla  grown  in  tho  test  tube  (in  vitro  tosts,  eg,  the 
Arnoe  test).  A  number  of  chcmicu\o  cause  cancer  by  horrnonol  or  other 
mochonioms  and  do  not  uhow  up  In  in  vitro  tosts,  thuo  whole  onimol  ntudies  oru 
U!.lod.  In  ouch  otudios  large  numbcrn  of  an!molo  hove  to  be  used  bocouoe  of  the 
natural  background  of  dincmm  ond  concor  in  all  specien.  Mutations  in  human 
gorm  cells  (sperm  ond  ova)  would  nh10  bo  harmful  aport  from  carcinogenic 
offocte  ond  tests for  mutogonir.ity  oro  nloo  carried  out with  thin  in  mind. 
Roproductivo  tmdcity.  Chomicnlo  mny  interfere  with  reproduction  nt  any  stage 
from  the  production  of  sperm  nnd  ovo  to  development  of  the  foetus  nnd 
newborn.  Animals  oro  douod  before  mating,  and  during  or  after  pregnancy.  The 
dovolopment  nnd  numbero  of  offspring  oro  nooonoed. 
Mutogonicity.  Chemicnlo  mny  also  cnune  permanent  changes  in  genes  \!/hich  arc 
pasood  along  to  descendent  cells.  A  number  of  animal  nnd  in  vitro  tests  covor 
tho  rongo  of  mutogoniclty  tests. 
lrritrulcy/corrooivity.  Substnncoo  can  cnu!le  damage  at  the  site  of  c,;ntact  (akin, 
oyo,  otc)  and  tests  for  loco!  irrltoncy  and  corro!liVe  damage  oro  !':ardocl  out, 
porticui<:~rly  for  induotriol  chomicolo.  (Irritation  in  tho  production  ·.:f  reversible 
tieouo  domago;  corronion  is  the  production  of  irrevel'siblc  tiss~Jc  damage). 
Sovoroly  irritont  proportics  of  uubstancos  cnn  usually  be  dotoctcd  in  vitro. 
Anlmol  testa  of  eye  irritancy  (Droize  teot)  can  clrJcide  whothor  a  cubstance  is 
mildly  irritant  or  non-irritant. Table  c·--
EEC  Directives  which  include  Animal  Testing  Requirement!> 
Directives  by  Subject  Area 
o  Trndc in animals 
Council Directive  of  26th  June  1964  on 
health  problems  affecting  intra-community 
trade in  bovine  animals  and  swine 
(Directive  6l!/l!32/EEC)  (O.T::C, 
29th  July  1964),  as  amended  by 
- Directive  80/219/EEC  (OJEC  L47,  21st 
February  1980) 
o  Animal  nutrition  products 
StatwJ  of  Requirement 
Explicit  in  text 
Explicit  in  text 
Council  Directive  of  18th  April  1983  on  the  Explicit  in  text 
fixing  of  guidelines  for  the  assessment 
of  certain  products  used  in  animal  nutrition 
(Directive  83/228/EEC) (O.T::C  L126,  13th  May 
1983) 
Council Directive  of  16th  February  1987  fixing  Explicit  in  text 
guidelines  for  the  assessment  of  additives 
in  animal  nutrition  (Directive  87/153/EEC) 
(OJEC  L64,  7th  March  1987) 
o  Veterinary  Medicinal  Products 
Council  Directive  of  28th  September  1981  on 
the  approximntion  of  the  laws  of  the  Member 
Stntes  relating  to  veterinnry  medicinal 
products  (Directive  81/851/EEC)  (OJEC,  L317, 
6th  November  1981) 
Implicit  in  safety 
cautions 
Council  Directive  of  28th  September  1981  on  Explicit  in  text 
the  approximation  of  the  laws  of  the  Member 
States  relating  to  analytical,  pharmaco-
toxicological  and  clinical  standards  and 
protocols  in  respect  of  the  testing  of  veter-
inary  medicinal  products  (Directive  81/852/ 
EEC)  (OJEC  L317,  6.11.81)  as  amended  by 
- Directive  87/20/EEC (OIC Ll5,  17th 
Jnnuary  1987)  Explicit  in  text 
o  Proprietary  medicinal  product!; 
Council  [)irective  of  26th  January  1965  on  the  Implicit 
npproximation  of  provisions  bid  down  by  lnw, 
regulation  or  administrntivc  action  relnting 
to  proprict8ry  medicinal  products  (Directive 
65/65/EEC)  (O.JEC,  9th  February  1965),  as 
nmcndcd  by 
'----------------Table · · 2  .  (Continued) 
EEC  Directive:J  which  include  Animal  TC!ltinQ  Requirements 
Directives  by Subject Area 
- Directive  83/570/EEC  (OJEC  L332,  28th 
November  1983) 
- Directive  87/21/EEC (OJEC  Ll5,  17th 
January  1987) 
Council Directive  of  20th  May  1975  on  the 
approximation  of  the  laws  of  Member  States 
relating  to  analytical,  pharmaco-
toxicological  nnd  clinical standards  and 
protocols  in  respect  of the  testing  of 
proprietary  medicinal  products (Directive 
75/318/EEC)  (OJEC  LllO,  9th  June  1975),  as 
amended  by 
- Directive  83/570/EEC  (OJEC  L332, 
28th  November  1983); 
Directive  87/19/EEC (OIC Ll5,  17th 
January  1987) 
Status  of  Requirement 
Explicit  in  text 
Implicit  in  safety 
cautions 
Explicit  in  text 
Explicit  in  text 
Explicit  in  te·xt 
Council  Recommendation  of  26th  October  1983  Explicit  in  text 
concerning  tests  relating  to  the  placing 
on  the  market  of proprietary  medicinal 
products  (Directive  83/571/EEC),  (OJEC 
L332,  28th  November  1983) 
Council  Recommendation  of  9th  February  1987  l::xplicit  in  text 
concerning  tests  relating  to  the  placing 
on  the  market of proprietary  medicinal 
products  (Directive  87/176/EEC)  (OJEC  L73 
16th  March  1987) 
o  Classification,  Packing and  Labelling of Dangerous  Preparations 
Council Directive  of  26th  June  1978  on  the 
approximation  of  the  laws  of  the  Member 
States  relating  to  the  classification, 
packaging  and  labelling  of  dangerous 
preparations  (pesticides)  (Directive 
78/631/EEC)  (OJEC  L206,  29th  July  1978) 
Explicit  in  text 
o  Classification,  Packing  and  Labelling  of Dangerous  Substances 
Council Directive  of  27th  Juno  1967  on  the 
approximation  of  laws,  regulations  and 
administrative  provision  relating  to  the 
classification,  packaging  and  labelling 
of dangerous  substances  (Directive 
67/5!~8/EEC) (OJEC  196,  16th  August  .1967), 
as  amended  by 
Implicit  in  clnssification 
and  labelling  requirements Table  2  ·  (Continued) 
EEC  Directives which  include  Animal  Testing  Requirements 
Directives  by Subject Area 
Directive 79/831/EEC (O.EC  L259, 
15th  October  1979); 
o  Food  Additives 
Status  of Requirement 
Explicit  in  text 
Commission  Recommendation  of  11th November  Implicit 
1980  to  the  Member  States  concerning  tests 
relating  to  the safety  evaluation  of  food 
additives  (Recommendation  80/1089/EEC) 
(OJEC  L320,  27th  November  1980)  Explicit  in  guidelines(!) 
o  Cosmetics 
Council Directive  of  27th  July  1976  on  the 
approximation  of  the  laws  of  the  Member 
States  relating  to  cosmetic  products 
(Directive  76/768/EEC)  (OJEC  L262,  27th 
September  19.76) 
Commission  Decision  of  19th  December  1977 
establishing  a  Scientific  Committee  on 
Costmetology  (Decision  78/45/EEL) 
(OJEC  L.13,  17th  January  1978) 
Implicit 
Implicit 
Explicit  in  guirlance 
notes(2) 
(1)  Report  of  the  Scientific  Committee  for  Food  on  "Guidelines  for  the  Safety. 
Assessment  of Food  Additives  (1980). 
(2)  Reports  of  the  Scientific  Committee  on  Cosmetology  (Third  Series)  "Notes 
of  Guidance  for  the  Toxicity  Testing  of  Cosmetic  Ingredients"  in  EEC 
Environment  and  Quality of  Life  (1983). Table  ;3  [ 
T  pes  of  AI tcrnntivcs  __  to_A_n_i_m._a_l_T_e_s_t_i_n_,g'---------------------.1 
Mathematical  Modelling  of  Structure-Activity  Relationnhips 
Graphics,  Network  Thermodynamic  Modelling 
and  Computer l 
Mathematical  modelling  based  on  chemical  structure:  at  an 
development. 
early  stage  of 
Mathematical  Modelling  of  Bio-chemical  and  Physiological  Processes 
Developed  on  the  basis  of  experimental  data,  including  animal  testing. 
I 
Human  Studies 
Direct  testing  of 
toiletries),  drugs. 
substances  intended  for  humnn  usc,  eg, 
! 
cosmetics  (nnd I 
I 
Epidemiological  research,  pmticularly  on  substances  to  which  humans  arc 
exposed  indirectly,  eg,  pesticides,  chemicals  used  in  the  workplnce. 
Use  of  Lower  Orgnnisms 
Includes  usc  of  bacterin,  algae,  protozoa,  coelenterates,  fungi,  plants;  insects, 
echinoderms,  molluscs. 
In-Vitro  Techniques 
Cell  cui tures:  obtained  from  hum  on  tissues  or  animals.  In  some  cases  a 
continuous  cell. line  may  be  established  from  a  primary  cell  culture;  a  great 
deal  of  work  is  being  curried  out  in  these  areas. 
Organ  cui tures:  obtained  from  donor  animals.  Many  organ  cui turcs  can  be 
established  from  each  donor  animal,  the  cultures  arc  compmatively  short-lived. 
Sub-cellular  functions:  e.g.  enzymes,  microsornes. 
Improved  Storage,  Exchange  and  Usc  of  Information 
Making  available  to  others  data  on  experiments  already 
permitting  animal  experimentation  only  where  the 
eventually  made  public. 
carried  out.  (Possibly) 
results  obtained  are 
Accepting  results  of  toxicity  testing  cnrried  out  in  other  countries/by  other· 
au thor  i ties. 
Harmonising  regulations  and  test  protocols  across  authorities. 
Improved  Design  of  Experiments 
Design  of  experiments  with  statisticians•  input  may  reduce  the  numbers  of 
animals  required,  a! though  there  arc  arguments  that  better  design  can  lead  to 
increased  numbers  of  animals. 
Stepwise  approach  (sec  2.2..3)  can  reduce  extent  of  animal  testing. 
Sequential  approach  to  acute  toxicity  testing  reduces  numbers  of  nrlirnals 
tested. 
Source:  Based  on  FRAME,  Alternatives  to  Animal  Experiments  Frame, 
Nottingham,  1985. Tnble  l+ 
Summary  of  the  Principal  Tent  Arcnn  where  Alternatives  arc  Oeing_  Developed 
Test Areas 
Acute  Toxicity 
Appraisal  of  acute 
toxic  potential 
required  for  chemi-
cals  which  may  be 
directly  or  indirectly 
(eg,  through  the 
environment)  ingested 
or  nbsorbcd. 
Long-Term  Toxicity 
Appraisal  required  for 
substances  to  which 
people  mny  be  directly 
or  indirectly  exposed 
over  n  long  period. 
Level  of  Concern 
Classic  measure  is 
LD5o:  widely  criti-
cised  on  animal  welfare 
grounds  nnd  by  some 
toxicologists. 
Not  under  particular 
public  scrutiny. 
Concern  to  develop 
alternatives  includes 
users  of  the  test 
because  of  cost  and 
time  involved. 
Cnrcinogenicity/Mutngenicity 
Evalu8tion  required  for 
substances  to  which 
people  m8y  be  directly 
or  indirectly  exposed. 
Reproductive  Toxicity 
Arproisol  of  intcr-
gencrCJtion  effects. 
Focus  of  concern  by 
public,  users  and  regu-
lators.  Standard  tests 
nrc  difficult  to  evnl-
uatc  nnd  time-consuming 
and  costly  to  run. 
Test  requirements  have 
increased  since  thali-
domide  disnstcr.  Arco 
where  pressure  is 
strong  for  more  Lc:.;ting. 
Development  of 
Alternatives 
Focus  of  nttention  in 
developing  nlternatives, 
particulnrly  refinement 
appronches.  Limit  tests 
and  approximate  LD5o 
testing  well-established 
in  regulations  though  not 
always  acceptable.  Other 
refinement  npproaches 
being  developed  too. 
May  be  scope  for  reduc-
ing  the  extent  of  testing 
in  terms  of  period  and 
dosnge;  potential  role  for 
in-vitro  approaches  for 
prelirninnry  screening  and 
identifying  modes  of 
action  but  more  bnsic 
resenrch  needed  to 
develop  and  assess  realis-
tic  replacement  approa-
ches. 
Area  where  replacement 
in-vitro  npproaches  being 
developed  nnd  used  in 
industry  for  screening  bul 
no  altcrnntives  yet 
ncceptable  for  regulatory 
purposes. 
In-vitro  tests  used  in 
some  R  nnd  D  work,  but 
not  to  grcot  cxlcnt  for 
regulatory  purpose:,. 
Possible  scope  for  reduc-
ing  unimal  testing  through 
twrmonising  test  require-
ments  and  exchange  of 
data. 
·····  ···---·----------------------Table  4  (Continued) 
Summar  of  the  Princi  al  Test  Areas  where  Alternatives  arc  Bein  ed 
Test Areas  Level  of  Concern 
Dermal  and  Ocular Irritancy/Corrosivity 
Important  for  substan-
ces  and  products 
directly  applied  to 
skin  or  eyes  or  to 
which  people  may  be 
exposed  at  the  work-
place. 
Sensitivity  Testing 
• An  expanding  area  as 
understanding  of  sensi-
tivity/allergy  grows. 
Draize  test in  particu-
lar  subject  to  much 
public/pressure  group 
opposition. 
Pressure  for  increased 
information  on  substan-
ces,  but  no  standardi-
sed  test  approaches 
developed. 
Development  of 
Alternatives 
Steps  taken  to  refine  pro-
cedures  to  reduce  num-
bers· of  animals  and  limit 
pain  and  suffering.  In-
vitro  alternatives  and  use 
of  isolated  eyes  being 
developed  towards  regula-
tory  acceptance. 
Area  where  there  may  be 
scope  for  research  into 
non-animal,  or  other 
alternative  approaches 
while  test  approaches  are 
being  developed. /I 
/ 
r-:;:T,-a~b.,....l  e- 5 
(. 
':}  -I 
I 
------------------~,.~~  , .-
Intcrr  Criteria for  Classifict!tion of Chemicals  bm;ed  on LD5o  Values 
United Nations 
Solid  Toxic  1  (<5)  Toxic  2  (<50)  Toxic  3  (<500) 
Liquid  Toxic  1  (<5)  Toxic  2  (<50)  Toxic  3  (<2,000) 
USA 
Super 
Toxic  (<5) 
Highly 
Toxic  (<50) 
Very 
Toxic  (<SOD) 
Moderately 








1  (<S) 
Category 




2  (<SO) 
Category' 
2  (<SO) 
Deleterious 
(<300) 
European Economic  Community 
Very  Toxic  (<200) 
Toxic  (<2S) 
Category 
3  (<500) 
Category 
3  (<SOD) 
Category 
4  (<5,000) 
Category 
4  (<2,000) 
Harmful  (<2,000) 




Toxic  (<S) 
Very 
Toxic  (<2S) 
World  Health Organisation 
Solid  Extremely 
Hazardous 
(  <5) 




Toxic  (<SO)  Harmful  (<SOD) 
Toxic  (<200)  Harmful  (<2,000) 
Highly  Moderately  Slightly 
Hazardous  Toxic  Toxic 
(<SO)  (<SOD)  (  <S,OOO) 
Highly  Moderately  Slightly 
Hazardous  Toxic  Toxic 
(<200)  (<2,000)  (<5,000) 
Category 
5  (<15,000) 
Category  ~ 
5  (<lS,OOO) 
The  classification  category  (cg,  Toxic  1)  is  followed  by  the  LD50  values  (in 
brackets)  in  rng/kg  bodywcight  which  define  the  limit  for  a  category. 